Top > News & Information > A new paper has been published.
A new paper has been published.
A study performed in collaboration with Prof. Hiroshi Handa, Tokyo Medical University, has been
published in iScience, a journal recently launched by Cell Press. This study has shown the novel function of cereblon (CRBN), the cellular target of thalidomide, using zebrafish as the model organism. Thus, overexpression of CRBN in zebrafish embryos results in an enlarged head and brain, whereas knockdown of CRBN results in a small head and brain. It was found that CRBN controls growth of neural stem cells. For more detail, please take a look at
Tokyo Tech News.